Co-utilization of a TLR5 agonist and nano-formulation of HIV-1 vaccine candidate leads to increased vaccine immunogenicity and decreased immunogenic dose: A preliminary study.
| Image |  |
|---|---|
| Description | scientific article published on 4 May 2017 |
| Author/s |
author: Mehdi Mahdavi |
| Publication date | May 4, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |